πŸ‡ΊπŸ‡Έ FDA
Patent

US 11149025

Anti-cancer compounds

granted A61KA61K31/502A61P

Quick answer

US patent 11149025 (Anti-cancer compounds) held by The Regents of the University of California expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/502, A61P, A61P35/00